Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples